O	0	8	Curcumin	Curcumin	NN	B-NP
O	9	16	induces	induce	VBZ	B-VP
O	17	26	apoptosis	apoptosis	NN	B-NP
O	27	29	in	in	IN	B-PP
O	30	42	immortalized	immortalize	VBN	B-NP
B-Cell	43	46	NIH	NIH	NN	I-NP
I-Cell	47	50	3T3	3T3	NN	I-NP
O	51	54	and	and	CC	O
B-Cell	55	64	malignant	malignant	JJ	B-NP
I-Cell	65	71	cancer	cancer	NN	I-NP
I-Cell	72	76	cell	cell	NN	I-NP
I-Cell	77	82	lines	line	NNS	I-NP
O	82	83	.	.	.	O

O	85	93	Curcumin	Curcumin	NNP	B-NP
O	93	94	,	,	,	O
O	95	100	which	which	WDT	B-NP
O	101	103	is	be	VBZ	B-VP
O	104	105	a	a	DT	B-NP
O	106	112	widely	widely	RB	I-NP
O	113	117	used	use	VBN	I-NP
O	118	125	dietary	dietary	JJ	I-NP
O	126	133	pigment	pigment	NN	I-NP
O	134	137	and	and	CC	I-NP
O	138	143	spice	spice	NN	I-NP
O	143	144	,	,	,	O
O	145	148	has	have	VBZ	B-VP
O	149	153	been	be	VBN	I-VP
O	154	166	demonstrated	demonstrate	VBN	I-VP
O	167	169	to	to	TO	I-VP
O	170	172	be	be	VB	I-VP
O	173	175	an	an	DT	B-NP
O	176	185	effective	effective	JJ	I-NP
O	186	195	inhibitor	inhibitor	NN	I-NP
O	196	198	of	of	IN	B-PP
B-Cancer	199	204	tumor	tumor	NN	B-NP
O	205	214	promotion	promotion	NN	I-NP
O	215	217	in	in	IN	B-PP
O	218	223	mouse	mouse	NN	B-NP
B-Organ	224	228	skin	skin	NN	I-NP
O	229	243	carcinogenesis	carcinogenesis	NN	I-NP
O	243	244	.	.	.	O

O	245	247	We	We	PRP	B-NP
O	248	254	report	report	VBP	B-VP
O	255	259	that	that	IN	B-SBAR
O	260	268	curcumin	curcumin	NN	B-NP
O	269	276	induces	induce	VBZ	B-VP
B-Cell	277	281	cell	cell	NN	B-NP
O	282	291	shrinkage	shrinkage	NN	I-NP
O	291	292	,	,	,	O
B-Cellular_component	293	302	chromatin	chromatin	NN	B-NP
O	303	315	condensation	condensation	NN	I-NP
O	315	316	,	,	,	O
O	317	320	and	and	CC	O
O	321	324	DNA	DNA	NN	B-NP
O	325	338	fragmentation	fragmentation	NN	I-NP
O	338	339	,	,	,	O
O	340	355	characteristics	characteristic	NNS	B-NP
O	356	358	of	of	IN	B-PP
O	359	368	apoptosis	apoptosis	NN	B-NP
O	368	369	,	,	,	O
O	370	372	in	in	IN	B-PP
O	373	385	immortalized	immortalize	VBN	B-NP
O	386	391	mouse	mouse	NN	I-NP
B-Cell	392	398	embryo	embryo	NN	I-NP
I-Cell	399	409	fibroblast	fibroblast	NN	I-NP
I-Cell	410	413	NIH	NIH	NN	I-NP
I-Cell	414	417	3T3	3T3	NN	I-NP
O	418	421	erb	erb	NN	I-NP
O	422	424	B2	B2	NN	I-NP
O	425	433	oncogene	oncogene	NN	I-NP
O	433	434	-	-	HYPH	B-VP
O	434	445	transformed	transform	VBN	B-NP
B-Cell	446	449	NIH	NIH	NN	I-NP
I-Cell	450	453	3T3	3T3	NN	I-NP
O	453	454	,	,	,	O
O	455	460	mouse	mouse	NN	B-NP
B-Cell	461	468	sarcoma	sarcoma	NN	I-NP
I-Cell	469	473	S180	S180	NN	I-NP
O	473	474	,	,	,	O
O	475	480	human	human	JJ	B-NP
B-Cell	481	486	colon	colon	NN	I-NP
I-Cell	487	493	cancer	cancer	NN	I-NP
I-Cell	494	498	cell	cell	NN	I-NP
I-Cell	499	501	HT	HT	NN	I-NP
I-Cell	501	502	-	-	HYPH	B-NP
I-Cell	502	504	29	29	CD	I-NP
O	504	505	,	,	,	O
O	506	511	human	human	JJ	B-NP
B-Cell	512	518	kidney	kidney	NN	I-NP
I-Cell	519	525	cancer	cancer	NN	I-NP
I-Cell	526	530	cell	cell	NN	I-NP
I-Cell	531	534	293	293	CD	I-NP
O	534	535	,	,	,	O
O	536	539	and	and	CC	O
O	540	545	human	human	JJ	B-NP
B-Cell	546	560	hepatocellular	hepatocellular	JJ	I-NP
I-Cell	561	570	carcinoma	carcinoma	NN	I-NP
I-Cell	571	574	Hep	Hep	NN	I-NP
I-Cell	575	577	G2	G2	NN	I-NP
I-Cell	578	583	cells	cell	NNS	I-NP
O	583	584	,	,	,	B-PP
O	585	588	but	but	CC	I-PP
O	589	592	not	not	RB	B-PP
O	593	595	in	in	IN	I-PP
O	596	603	primary	primary	JJ	B-NP
B-Cell	604	611	culture	culture	NN	I-NP
O	612	614	of	of	IN	B-PP
O	615	620	mouse	mouse	NN	B-NP
B-Cell	621	630	embryonic	embryonic	JJ	I-NP
I-Cell	631	641	fibroblast	fibroblast	NN	I-NP
I-Cell	642	645	C3H	C3H	NN	I-NP
I-Cell	646	650	10T1	10T1	NN	I-NP
I-Cell	650	651	/	/	SYM	O
I-Cell	651	652	2	2	CD	B-NP
O	652	653	,	,	,	O
O	654	657	rat	rat	NN	B-NP
B-Cell	658	667	embryonic	embryonic	JJ	I-NP
I-Cell	668	678	fibroblast	fibroblast	NN	I-NP
O	678	679	,	,	,	O
O	680	683	and	and	CC	O
O	684	689	human	human	JJ	B-NP
B-Cell	690	698	foreskin	foreskin	NN	I-NP
I-Cell	699	709	fibroblast	fibroblast	NN	I-NP
I-Cell	710	715	cells	cell	NNS	I-NP
O	716	718	in	in	IN	B-PP
O	719	720	a	a	DT	B-NP
O	721	734	concentration	concentration	NN	I-NP
O	734	735	-	-	HYPH	O
O	736	739	and	and	CC	O
O	740	744	time	time	NN	B-NP
O	744	745	-	-	HYPH	B-NP
O	745	754	dependent	dependent	JJ	I-NP
O	755	761	manner	manner	NN	I-NP
O	761	762	.	.	.	O

O	763	767	Many	Many	JJ	B-NP
B-Cell	768	776	cellular	cellular	JJ	I-NP
O	777	780	and	and	CC	I-NP
O	781	792	biochemical	biochemical	JJ	I-NP
O	793	800	effects	effect	NNS	I-NP
O	801	803	of	of	IN	B-PP
O	804	812	curcumin	curcumin	NN	B-NP
O	813	815	in	in	IN	B-PP
O	816	821	mouse	mouse	NN	B-NP
B-Cell	822	832	fibroblast	fibroblast	NN	I-NP
I-Cell	833	838	cells	cell	NNS	I-NP
O	839	843	have	have	VBP	B-VP
O	844	848	been	be	VBN	I-VP
O	849	857	reported	report	VBN	I-VP
O	857	858	,	,	,	O
O	859	863	such	such	JJ	B-PP
O	864	866	as	as	IN	I-PP
O	867	877	inhibition	inhibition	NN	B-NP
O	878	880	of	of	IN	B-PP
O	881	888	protein	protein	NN	B-NP
O	889	895	kinase	kinase	NN	I-NP
O	896	897	C	C	NN	I-NP
O	898	899	(	(	(	O
O	899	902	PKC	PKC	NN	B-NP
O	902	903	)	)	)	O
O	904	912	activity	activity	NN	B-NP
O	913	920	induced	induce	VBN	B-VP
O	921	923	by	by	IN	B-PP
O	924	931	phorbol	phorbol	NN	B-NP
O	932	934	12	12	CD	I-NP
O	934	935	-	-	HYPH	O
O	935	944	myristate	myristate	NN	B-NP
O	945	947	13	13	CD	I-NP
O	947	948	-	-	HYPH	I-NP
O	948	955	acetate	acetate	NN	I-NP
O	956	965	treatment	treatment	NN	I-NP
O	965	966	,	,	,	O
O	967	977	inhibition	inhibition	NN	B-NP
O	978	980	of	of	IN	B-PP
O	981	989	tyrosine	tyrosine	NN	B-NP
O	990	997	protein	protein	NN	I-NP
O	998	1004	kinase	kinase	NN	I-NP
O	1005	1013	activity	activity	NN	I-NP
O	1013	1014	,	,	,	O
O	1015	1018	and	and	CC	O
O	1019	1029	inhibition	inhibition	NN	B-NP
O	1030	1032	of	of	IN	B-PP
O	1033	1044	arachidonic	arachidonic	JJ	B-NP
O	1045	1049	acid	acid	NN	I-NP
O	1050	1051	(	(	(	O
O	1051	1053	AA	AA	NN	B-NP
O	1053	1054	)	)	)	O
O	1055	1065	metabolism	metabolism	NN	B-NP
O	1065	1066	.	.	.	O

O	1067	1076	Treatment	Treatment	NN	B-NP
O	1077	1079	of	of	IN	B-PP
B-Cell	1080	1083	NIH	NIH	NN	B-NP
I-Cell	1084	1087	3T3	3T3	NN	I-NP
I-Cell	1088	1093	cells	cell	NNS	I-NP
O	1094	1098	with	with	IN	B-PP
O	1099	1102	the	the	DT	B-NP
O	1103	1106	PKC	PKC	NN	I-NP
O	1107	1116	inhibitor	inhibitor	NN	I-NP
O	1117	1130	staurosporine	staurosporine	NN	I-NP
O	1130	1131	,	,	,	O
O	1132	1135	the	the	DT	B-NP
O	1136	1144	tyrosine	tyrosine	NN	I-NP
O	1145	1151	kinase	kinase	NN	I-NP
O	1152	1161	inhibitor	inhibitor	NN	I-NP
O	1162	1172	herbimycin	herbimycin	NN	I-NP
O	1173	1174	A	A	NN	I-NP
O	1174	1175	,	,	,	O
O	1176	1179	and	and	CC	O
O	1180	1183	the	the	DT	B-NP
O	1184	1186	AA	AA	NN	I-NP
O	1187	1197	metabolism	metabolism	NN	I-NP
O	1198	1207	inhibitor	inhibitor	NN	I-NP
O	1208	1218	quinacrine	quinacrine	NN	I-NP
O	1219	1226	induces	induce	VBZ	B-VP
O	1227	1236	apoptotic	apoptotic	JJ	B-NP
B-Cell	1237	1241	cell	cell	NN	I-NP
O	1242	1247	death	death	NN	I-NP
O	1247	1248	.	.	.	O

O	1249	1254	These	These	DT	B-NP
O	1255	1262	results	result	NNS	I-NP
O	1263	1270	suggest	suggest	VBP	B-VP
O	1271	1275	that	that	IN	B-SBAR
O	1275	1276	,	,	,	O
O	1277	1279	in	in	IN	B-PP
O	1280	1284	some	some	DT	B-NP
O	1285	1297	immortalized	immortalize	VBN	I-NP
O	1298	1301	and	and	CC	I-NP
O	1302	1313	transformed	transform	VBN	I-NP
B-Cell	1314	1319	cells	cell	NNS	I-NP
O	1319	1320	,	,	,	O
O	1321	1329	blocking	block	VBG	B-VP
O	1330	1333	the	the	DT	B-NP
B-Cell	1334	1342	cellular	cellular	JJ	I-NP
O	1343	1349	signal	signal	NN	I-NP
O	1350	1362	transduction	transduction	NN	I-NP
O	1363	1368	might	might	MD	B-VP
O	1369	1376	trigger	trigger	VB	I-VP
O	1377	1380	the	the	DT	B-NP
O	1381	1390	induction	induction	NN	I-NP
O	1391	1393	of	of	IN	B-PP
O	1394	1403	apoptosis	apoptosis	NN	B-NP
O	1403	1404	.	.	.	O

